THERAHEMP Trademark

Trademark Overview


On Wednesday, January 30, 2019, a trademark application was filed for THERAHEMP with the United States Patent and Trademark Office. The USPTO has given the THERAHEMP trademark a serial number of 88282891. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 2, 2020. This trademark is owned by LINNEA S.A.. The THERAHEMP trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; chemicals for use in the cosmetics and food industry; botanical extracts for use in the cosmetics and food indus...

Pharmaceuticals based on botanical and plant extracts; pharmaceuticals based on botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders
therahemp

General Information


Serial Number88282891
Word MarkTHERAHEMP
Filing DateWednesday, January 30, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, April 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; chemicals for use in the cosmetics and food industry; botanical extracts for use in the cosmetics and food industry; botanical extracts for use in the manufacture of cosmetics and dietary supplements; plant extracts, active substances and active chemical ingredients for use in the cosmetics and food industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements
Goods and ServicesPharmaceuticals based on botanical and plant extracts; pharmaceuticals based on botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, February 22, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCRYSTAL HEMP S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLugano CH-6900
CH

Party NameLINNEA S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRiazzino CH-6595
CH

Trademark Events


Event DateEvent Description
Thursday, April 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, April 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 16, 2019NON-FINAL ACTION E-MAILED
Monday, September 16, 2019NON-FINAL ACTION WRITTEN
Monday, September 9, 2019ASSIGNED TO EXAMINER
Wednesday, February 27, 2019ASSIGNED TO EXAMINER
Friday, February 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 2, 2019NEW APPLICATION ENTERED IN TRAM